Dr. William Goldstein, M.D. Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 30 Branch Brook Rd, Wilton, CT 06897 Phone: 203-981-8636 |
Kelly Ann Harkins-squitieri, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 64 Nod Hill Rd, Wilton, CT 06897 Phone: 203-767-1671 |
News Archive
Colon cancer patients who eat a diet high in red meat, fatty products, refined grains, and desserts a so-called Western diet may be increasing their chance of disease relapse and early death, report researchers at Dana-Farber Cancer Institute.
Omeros Corporation today announced dosing of the first patient in a second Phase 2 clinical trial of OMS824, the company's phosphodiesterase 10 (PDE10) inhibitor being developed for the treatment of schizophrenia, Huntington's disease (HD) and other cognitive disorders. The Phase 2 trial will evaluate the tolerability, safety, pharmacokinetics and performance on a battery of tests in patients with symptomatic HD.
To prevent medical mishaps with patients caused by telephone communication failures, researchers at Yale School of Medicine and the VA Connecticut Healthcare System report in the October issue of Journal of General Internal Medicine that expanded physician and residency training in telephone medicine is needed.
NeoTract, a wholly owned subsidiary of Teleflex Incorporated focused on addressing unmet needs in the field of urology, today announced that the American Urological Association has recommended the use of the UroLift System as a standard of care treatment for lower urinary tract symptoms due to benign prostatic hyperplasia.
XenoPort, Inc. announced today favorable preliminary results from a Phase 1 clinical trial in healthy adults designed to assess the pharmacokinetics (PK), safety and tolerability of single doses of four different oral formulations of XP23829, a novel fumaric acid ester compound that is a prodrug of monomethyl fumarate (MMF).
› Verified 3 days ago